Filing Details

Accession Number:
0001683168-24-002940
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-02 20:20:51
Reporting Period:
2024-04-30
Accepted Time:
2024-05-02 20:20:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
704562 Avid Bioservices Inc. CDMO Pharmaceutical Preparations (2834) 953698422
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1974519 R. Matthew Kwietniak 14191 Myford Road
Tustin CA 92780
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2024-04-30 1,233 $7.40 21,797 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSUs") which vested on April 9, 2024 and April 11, 2024. This sale does not represent a discretionary trade by the reporting person. For further information regarding the RSUs vested on April 9, 2024, refer to footnotes 2 and 3 of the reporting person's Form 4 filed with the SEC on April 11, 2024. For further information regarding the RSUs vested on April 11, 2024, refer to footnote 2 of the reporting person's Form 4 filed with the SEC on April 12, 2024.
  2. Represents a weighted average sales price per share. These shares were sold at prices ranging from $7.26 to $7.40. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.